BB vs PLX · P/E 117, rev $549.1M vs P/E 31, rev $53.4M
BlackBerry Ltd (BB) versus Protalix Biotherapeutics Inc (PLX) — a side-by-side from cached financials, not a winner call.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Latest reported PLX revenue for 2024-12-31 was $53.4M. Net income was $2.9M. Revenue was down 18.5% from 2023-12-31 to 2024-12-31. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
BB currently screens at market cap $6.14B and trailing P/E 116.5. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Not investment advice. Open the BB and PLX stock pages for the full models.
Not investment advice.